Benzinga | Sep 28, 2020 08:56AM EDT

Ladenburg Thalmann Initiates Coverage On Anavex Life Sciences with Buy Rating, Announces Price Target of $12

Ladenburg Thalmann analyst Robert LeBoyer initiates coverage on Anavex Life Sciences (NASDAQ:AVXL) with a Buy rating and announces Price Target of $12.Ladenburg Thalmann analyst Robert LeBoyer initiates coverage on Anavex Life Sciences (NASDAQ:AVXL) with a Buy rating and announces Price Target of $12.